DR NATALIA NOVAC
Senior Director, Emerging Technology & Innovation, Corporate Business Development, Eli Lilly
Natalia Novac is a Senior Director in Emerging Technology and Innovation Team at Eli Lilly Corporate Business Development in London and is responsible for search and evaluation of novel transformative healthcare technologies across all Eli Lilly indications in Europe. In her role, Natalia is also involved in the scientific evaluation of novel life science assets coming from several venture funds where Eli Lilly participates as a limited partner. As a part of Global Corporate Business Development Natalia supports general due diligence and deal process ensuring that scientific excellence and breakthrough technologies are not overlooked.
Natalia worked in the pharmaceutical industry for the past 15 years and has a solid academic background in oncology, endocrinology, immunology and multiple sclerosis. Natalia has a Diploma in Biochemistry, MSc in Microbiology and PhD in Molecular Biology.
20 May 2021
BOOK YOUR PLACE NOW